Exane Derivatives Docusign, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Docusign, Inc. stock. As of the latest transaction made, Exane Derivatives holds 179 shares of DOCU stock, worth $15,268. This represents 0.01% of its overall portfolio holdings.
Number of Shares
179
Previous 179
-0.0%
Holding current value
$15,268
Previous $19,000
47.37%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding DOCU
# of Institutions
795Shares Held
160MCall Options Held
5.37MPut Options Held
4.51M-
Vanguard Group Inc Valley Forge, PA21.9MShares$1.87 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.6MShares$1.24 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.84MShares$583 Million0.05% of portfolio
-
State Street Corp Boston, MA5.37MShares$458 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO4.48MShares$382 Million0.17% of portfolio
About DOCUSIGN, INC.
- Ticker DOCU
- Exchange NASDAQ
- Sector Technology
- Industry Software—Application
- Shares Outstandng 200,779,008
- Market Cap $17.1B
- Description
- DocuSign, Inc. provides electronic signature software in the United States and internationally. The company provides e-signature solution that enables businesses to digitally prepare, sign, act on, and manage agreements. It also offers CLM, which automates workflows across the entire agreement process; Insights that use artificial intelligence (...